Properties (51)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Company
|
| gptkbp:acquisition |
Celerion (2021)
Capsugel_(2017) InterHealth_Nutraceuticals_(2018) KBI_Biopharma_(2021) PharmaCell_(2021) Synlogic_(2021) |
| gptkbp:awards |
Sustainability Award (2020)
Innovation Award (2021) Best Workplace Award (2021) Excellence in Manufacturing Award (2021) Top Employer Award (2021) |
| gptkbp:CEO |
gptkb:Marc_Funk
|
| gptkbp:community_engagement |
Sponsorship of Local Events
STEM Education Programs Local Community Support Initiatives Employee_Volunteer_Programs Health_and_Wellness_Programs |
| gptkbp:employees |
15,000 (2020)
|
| gptkbp:founded |
1897
|
| gptkbp:global_presence |
Sales offices worldwide
Operations in 30 countries R&D_centers_in_Switzerland,_the_USA,_and_Singapore Manufacturing_sites_in_Europe,_North_America,_and_Asia |
| gptkbp:headquarters |
gptkb:Basel,_Switzerland
|
| https://www.w3.org/2000/01/rdf-schema#label |
Lonza Group
|
| gptkbp:industry |
Pharmaceuticals
|
| gptkbp:partnerships |
AstraZeneca_(2020)
Bristol-Myers_Squibb_(2020) Johnson_&_Johnson_(2020) Moderna_(2020) Novartis_(2020) |
| gptkbp:products |
Biologics
Small Molecules |
| gptkbp:researchAndDevelopment |
Vaccines
Biopharmaceuticals Nutraceuticals Cell and Gene Therapy |
| gptkbp:revenue |
5.3 billion CHF (2020)
|
| gptkbp:services |
Contract Manufacturing
|
| gptkbp:stockExchange |
gptkb:SIX_Swiss_Exchange
LONN |
| gptkbp:subsidiary |
gptkb:Lonza_Biologics
gptkb:Lonza_Pharma_&_Biotech gptkb:Lonza_Specialty_Ingredients |
| gptkbp:sustainability_initiatives |
Circular Economy
Sustainable Sourcing Employee Engagement Programs Carbon Neutrality by 2025 Water Stewardship |
| gptkbp:website |
www.lonza.com
|